[go: up one dir, main page]

RU93043610A - PHARMACEUTICAL COMPOSITION FOR STRENGTHENING OF PRIMARY IMMUNO REACTION IN MAMMALS, METHOD FOR STRENGTHENING OF PRIMARY IMMUNO REACTION AND USE OF INTERLEUKIN-4 FOR STRENGTHENING OF PRIMARY URIMCHEMI URICHEMA - Google Patents

PHARMACEUTICAL COMPOSITION FOR STRENGTHENING OF PRIMARY IMMUNO REACTION IN MAMMALS, METHOD FOR STRENGTHENING OF PRIMARY IMMUNO REACTION AND USE OF INTERLEUKIN-4 FOR STRENGTHENING OF PRIMARY URIMCHEMI URICHEMA

Info

Publication number
RU93043610A
RU93043610A RU93043610/13A RU93043610A RU93043610A RU 93043610 A RU93043610 A RU 93043610A RU 93043610/13 A RU93043610/13 A RU 93043610/13A RU 93043610 A RU93043610 A RU 93043610A RU 93043610 A RU93043610 A RU 93043610A
Authority
RU
Russia
Prior art keywords
strengthening
primary
immuno reaction
mammals
pharmaceutical composition
Prior art date
Application number
RU93043610/13A
Other languages
Russian (ru)
Inventor
Рожен Эдвард
О Коннелл Джон
Кокс Стюарт
Хейр Майкл
Швартц Джиром
Original Assignee
Шеринг Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Шеринг Корпорейшн filed Critical Шеринг Корпорейшн
Publication of RU93043610A publication Critical patent/RU93043610A/en

Links

Claims (1)

Предлагаются применение ИЛ-4 для приготовления лекарственного средства, фармацевтическая композиция, включающая ИЛ-4, и фармацевтически приемлемый носитель, а также способ усиления первичной иммуно-реакции млекопитающего на воздействие иммуногенов, находящихся в вакцине, например в вакцине анатоксина столбняка, путем введения таким млекопитающим эффективного количества ИЛ-4, предпочтительно рекомбинантного Е. coli - производного ИЛ-4 человека вместе с указанной вакциной.The use of IL-4 for the preparation of a medicament is proposed, a pharmaceutical composition comprising IL-4 and a pharmaceutically acceptable carrier, as well as a method of enhancing a mammalian primary immune response to the effects of immunogens present in a vaccine, for example, tetanus toxoid vaccine, by administration to such mammals an effective amount of IL-4, preferably recombinant E. coli, a derivative of human IL-4, together with the specified vaccine.
RU93043610/13A 1990-12-19 1991-12-17 PHARMACEUTICAL COMPOSITION FOR STRENGTHENING OF PRIMARY IMMUNO REACTION IN MAMMALS, METHOD FOR STRENGTHENING OF PRIMARY IMMUNO REACTION AND USE OF INTERLEUKIN-4 FOR STRENGTHENING OF PRIMARY URIMCHEMI URICHEMA RU93043610A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US629,800 1990-12-19

Publications (1)

Publication Number Publication Date
RU93043610A true RU93043610A (en) 1997-02-10

Family

ID=

Similar Documents

Publication Publication Date Title
NZ291262A (en) E. coli heat-labile enterotoxin derivatives and their use as oral adjuvants
CA2215203A1 (en) Vaccines for plague
AU7589587A (en) Low dosage of interferon to enhance vaccine efficiency
NO301577B1 (en) Method for Preparing a Stable Vaccine Mix and Method for Stabilizing Interleukin in a Vaccine Mix
RU94046232A (en) Vaccine composition, use of composition, treatment methods, method of composition preparing
CA2169764A1 (en) Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies
KR880000098A (en) Chondroitin Sulfate Immunostimulatory Composition
MX9304089A (en) USE OF GM-CSF AS AN ADJUVANT VACCINE.
EP0327640A4 (en) Immunotherapeutic compositions for the treatment of acquired immune deficiency syndrome.
OA09863A (en) Use of IL-4 to enhance immune response to immunogens in vaccines.
Bessler et al. Bacterial cell wall components as immunomodulators—II. The bacterial cell wall extract OM-85 BV as unspecific activator, immunogen and adjuvant in mice
RU93043610A (en) PHARMACEUTICAL COMPOSITION FOR STRENGTHENING OF PRIMARY IMMUNO REACTION IN MAMMALS, METHOD FOR STRENGTHENING OF PRIMARY IMMUNO REACTION AND USE OF INTERLEUKIN-4 FOR STRENGTHENING OF PRIMARY URIMCHEMI URICHEMA
IL84312A0 (en) Ifosfamide lyophilisate and its preparation
OA09672A (en) Use of il-4 to enhance immune response to infectious antigenic challenges
IT1217314B (en) SYNTHETIC NONAPEPTIDE WITH ADJUVANT ACTIVITY CAPABLE OF ENHANCING THE ANTI-CORPORAL RESPONSE IN VIVO
EP0351876A2 (en) Composition for potentiating vaccination effect
GR3006999T3 (en)
ATE99955T1 (en) IMMUNOLOGICALLY ACTIVE PEPTIDE CONJUGATE PPD-(NANP)N USE AS AN ANTI-MALARIA VACCINE.
SU1580617A1 (en) Method of preparing vaccine against influenza virus
KR890009976A (en) Synthetic peptides, compositions comprising them and methods of inducing immunity using the compositions
RU93005036A (en) METHOD OF TREATMENT OF THE VIRUS OF HUMAN IMMUNODEFICIENCY